Introduction: reducing the incidence of new HIV infections is a public health goal. The purpose of this study was to evaluate the knowledge and willingness to prescribe PrEP in Kinshasa.
Methods: we conducted a cross-sectional analytical study among care providers of 4 health facilities where HIV treatment was offered in the city of Kinshasa from April to October 2017. Univariate and multivariate logistic regression analyses were carried out to identify the factors associated with knowledge and willingness to prescribe PrEP.
Results: eighty-five care providers responded at the survey. Less than one quarter of care providers knew PrEP before the survey and half of them were willing to prescribe it. Reluctance was due to resistance (83%). Factors associated with the knowledge of PrEP were the specialty of infectious disease and the expertise in addressing HIV. Factors associated with the willingness to prescribe PrEP were an age greater than 40 years, the specialty of infectious disease and the expertise in addressing HIV.
Conclusion: the knowledge of the PrEP in Kinshasa was low and only half of care providers were willing to prescribe it. Being an infectious diseases specialist and an expert in HIV was associated with the knowledge and the willingness to prescribe PrEP. Education programs should strengthen the knowledge on PrEP and address concerns leading to reluctance to prescribe it.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046106 | PMC |
http://dx.doi.org/10.11604/pamj.2019.34.166.18025 | DOI Listing |
Antibiotics (Basel)
December 2024
Institute for Clinical Microbiology and Hygiene, University Clinic Regensburg, 93053 Regensburg, Germany.
Antimicrobial resistance poses a significant global health threat, partly due to the overprescription of antibiotics. Understanding prescribers' behaviors and identifying knowledge gaps and misconceptions are essential for addressing antibiotic misuse and inappropriate use. Through online questionnaires, this study surveyed key stakeholders in outpatient antibiotic use in Germany (DE) and Poland (PL), including patients, physicians, and pharmacists.
View Article and Find Full Text PDFPublic Health Nurs
December 2024
Clinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institut, Université Catholique de Louvain, Woluwé, Belgium.
Background: Deprescribing is a strategy to optimize medication use and to prevent medication harm. Despite the fact that behavioral theories have been shown to be useful in explaining health behaviors, the literature on deprescribing relies almost exclusively on attitudes as an explanatory factor for deprescribing behavior. This study systematically reviews the literature that made explicit use of the constructs included in health behavior theories (HBTs) to explain older adults' and informal caregivers' deprescribing behavior and outcomes.
View Article and Find Full Text PDFJAC Antimicrob Resist
February 2025
College of Medicine and Health, University of Birmingham, Birmingham, UK.
Objectives: In the West Bank, antimicrobial resistance (AMR) is increasingly and alarmingly common. Efforts are being made to introduce antimicrobial stewardship programmes (ASPs). This study explores doctors' perceptions of AMR and context-specific barriers and facilitators to ASPs at a critical point in national ASP development.
View Article and Find Full Text PDFAIDS Educ Prev
December 2024
Department of Health Promotion & Behavioral Sciences, The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Houston, Texas.
Of 1.2 million Americans who would benefit from pre-exposure prophylaxis (PrEP), only 36% were prescribed PrEP in 2023. Project HOMES is an ongoing study that evaluates recovery residences for individuals in medication-assisted recovery from opioid use disorder across five Texas cities.
View Article and Find Full Text PDFPLoS One
December 2024
Department of Clinical and Pharmaceutical Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.
Deprescribing is defined as the reduction of medications to improve patient care. For effective deprescribing regular evaluation of medication adjustment regimens is required as it is documented to be an effective method to reduce polypharmacy and potentially inappropriate medications while improving patient well-being. Several factors, including patient-related aspects, influence the deprescribing process.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!